Uploaded September 2026 | Updated November 2026, 11 hours ago
Amy Waldman, MD, pediatric neurologist and Medical Director of the Leukodystrophy Center at the Children’s Hospital of Philadelphia, discusses the approval of zilganersen to treat patients with Alexander disease.
Amy Waldman, MD, pediatric neurologist and Medical Director of the Leukodystrophy Center at the Children’s Hospital of Philadelphia, discusses the approval of zilganersen to treat patients with Alexander disease.










